ITM Isotope Technologies Munich SE

Earlier this week, we asked you: What is the system used by radiation oncologists to guide placement of needles for cancer treatment, and who was it named after? 💡 42 % of you knew the correct answer: “Quimby Rules” named after Edith H. Quimby, ScD: A pioneer whose work shaped the future of cancer treatment and #innovation for decades. As a professor of #radiology at the College of Physicians and Surgeons in the United States, Dr. Quimby was a revolutionary medical physicist who helped establish the therapeutic use of X-rays and radium in the early 20th century. Her groundbreaking #research focused on understanding the effects of radiation on patients and developing methods to calculate personalized radiation doses that minimized side effects. She was among the first scientists to demonstrate how optimized radiotherapy doses and treatment schedules could significantly improve patient outcomes, setting new standards in cancer care. Learn more about her incredible achievements and why we are highlighting her as an extraordinary woman during #WomensHistoryMonth:

🌟 Celebrating #WomensHistoryMonth 🌟 As we continue to honor the remarkable contributions of women to science, medicine, and society, we’re sharing more insights from our team. This week, our colleagues reflect on the women who inspire them most when they think about these fields. Here are four more perspectives celebrating the extraordinary achievements of women who have shaped history and those who continue to inspire us in our everyday lives. 💡 Let’s keep the celebration going—stay tuned for our final installment next week and don’t forget to join our quiz! Cast your vote in this week’s poll and check back on Friday for the answer: https://lnkd.in/dnErSi7D   #WomenInSTEM #Equality

March marks #WomensHistoryMonth —a time to honor and celebrate the remarkable impact women have had on society. Last week, we asked about a trailblazing woman in science—Maria Skłodowska-Curie. This week, we want to test your knowledge again! Let's see how much you know about the women, who have made significant contributions to nuclear medicine and cancer research. #WomeninSTEM #WomeninScience

Earlier this week, in our mini trivia quiz, we asked you: Which renowned female chemist had a unit of radioactivity named after her? 💡 95 % of you knew the correct answer: Maria Skłodowska-Curie, a trailblazer whose groundbreaking work revolutionized science and changed the world forever. 🌍 Born in Poland in 1867, she overcame immense societal barriers to become a world-renowned scientist. She made history as the first person to win Nobel Prizes in two distinct scientific fields: Physics in 1903 and Chemistry in 1911. Her discoveries of radium and polonium revolutionized the understanding of #radioactivity and laid the foundation for advancements in cancer treatment and scientific #research. During World War I, she further demonstrated her dedication to humanity by developing mobile X-ray units, saving countless lives on the battlefield. The curie (symbol Ci) is a non-SI unit of radioactivity, originally defined in 1910 and named in honor of Marie Skłodowska-Curie and Pierre Curie. It was initially intended to represent the activity of one gram of radium-226. In 1975, the becquerel (Bq), defined as one nuclear decay per second, was officially adopted as the SI unit of activity. According to the U.S. Environmental Protection Agency (EPA), the curie continues to be used in certain fields such as industry and medicine, particularly in the USA. Learn more about her incredible achievements and why we are highlighting her as an extraordinary woman during #WomensHistoryMonth:

Today, we’re announcing an important transition within ITM’s commercial leadership. After nearly two decades of dedicated service and stewardship, Dr. Sebastian Marx, Executive Board member and Chief Business Officer, has decided to step down from the Executive Board and will depart ITM in July 2025. Until then, he will remain in his role to ensure a seamless transition and continue advancing ITM’s business. Effective April 1, 2025, Roger Estafanos, currently U.S. General Manager, and Alexander Pironi, currently Senior Vice President, Commercial Strategy and Services, will take on leadership roles overseeing ITM’s radiopharmaceutical and medical radioisotope businesses, respectively. Upon Sebastian’s departure, they will report to ITM CEO, Dr. Andrew Cavey. A heartfelt thank you to Sebastian for his invaluable contributions in shaping ITM’s success — building our commercial business and partnerships with hospitals, research institutions, physicians, and pharmaceutical companies worldwide. We’re excited to welcome Roger and Alexander into their new roles and look forward to this next chapter for ITM.   Read more here 👉 https://lnkd.in/d5JiU_RX

🌟 Celebrating #WomensHistoryMonth 🌟 Throughout March, we honor the incredible contributions of women to #science, #medicine, and #society. We asked our colleagues: Which women inspire you the most when thinking about historical milestones in these fields?   Here are four inspiring perspectives from our team, highlighting the extraordinary achievements of women who have shaped our world. 💡 Stay tuned for more inspiring voices from our team in the coming weeks as we continue to celebrate Women’s History Month together. We also invite you to participate in our ongoing quiz! Share your thoughts in the poll, and stay tuned for the correct answer this Friday: https://lnkd.in/dY4Wa3-k #WomenInSTEM #Equality

Congratulations, Dr. Jaume Capdevila for winning First Place for the Best Oral Abstract Presentation in the #ClinicalScience category at the European Neuroendocrine Tumor Society e.V. (ENETS) Conference 2025. Dr. Capdevila presented the positive topline results from our #Phase3 COMPETE trial, demonstrating a clinically and statistically significant improvement in progression-free survival (PFS) with n.c.a. ¹¹⁷Lu-edotreotide (ITM-11) compared to everolimus in patients with Grade 1/2 gastroenteropancreatic neuroendocrine tumors (#GEPNETs) in Krakow, Poland. 👏 We extend our heartfelt gratitude and warmly congratulate you on this truly well-deserved recognition!

March marks Women's History Month – a time to honor and celebrate the remarkable impact women have had on society. For us, it’s also an opportunity to spotlight the women who have shaped the fields of #NuclearMedicine and #CancerResearch. Think you know the early female pioneers in these fields? Test your knowledge with us each week this month—we can’t wait to see how much you know! #WomeninSTEM #WomeninScience

Yesterday marked the final day of the European Neuroendocrine Tumor Society e.V. (ENETS) Conference 2025, and we’re reflecting on a few truly inspiring days filled with innovative ideas, impactful discussions on the future of #healthcare, and meaningful connections. Missed some of the highlights? Don’t worry—we’ve got you covered! Watch exclusive expert videos featuring nuclear medicine physician Chiara Maria Grana and medical oncologist Jaume Capdevila, who shared their valuable insights live from Krakow. Check them out here: https://lnkd.in/d8-2tiv9 In honor of #InternationalWomensDay and this year’s ITM theme, “Celebrating Women, Championing Change,” we have one more special video to share! We asked conference attendees which women in science and research have inspired them the most. Watch the video and join the conversation—who inspires you? ✨   #IWD #IWD25 #WomensDay #WomenInScience